Because Olfr734 is involved in the pathophysiology of different diseases associated with obesity, such as T2DM and MASLD, identifying the molecular mechanisms underlying these disorders will help identify more effective methods for their prevention and treatment. This evidence concerns the gene OR4M1 and metabolic dysfunction-associated steatotic liver disease.